Greater Cannabis Company (GCAN) Share-based Compensation (2017 - 2025)

Greater Cannabis Company (GCAN) recorded quarterly Share-based Compensation of $1800.0 in Q1 2025, down 85.31% quarter-over-quarter from $12250.0 in Q3 2019.

Greater Cannabis Company (GCAN) Share-based Compensation (2017 - 2025) Analysis & Trends

Greater Cannabis Company's Share-based Compensation history runs 4 years deep, the most recent figure standing at $1800.0 for Q1 2025.

  • In Q1 2025, Share-based Compensation changed N/A year-over-year to $1800.0; the TTM figure through Mar 2025 stood at $14050.0 (changed N/A YoY), while the FY2019 annual figure was $88130.0, changed N/A from the prior year.
  • Share-based Compensation was $1800.0 for Q1 2025 at Greater Cannabis Company, down from $12250.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1800.0 in Q1 2025 to a low of $1800.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 43.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 25.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 33.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -395,114.54
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 57.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 21.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 36.33 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 16.04 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 36.86 Mn
10 Greater Cannabis Company - - - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1,800.00
Mar 31, 2025 1,800.00
Sep 30, 2019 12,250.00
Sep 30, 2019 12,250.00
Mar 31, 2018 2,500.00
Mar 31, 2018 2,500.00
Dec 31, 2017 -522,500.00
Dec 31, 2017 -522,500.00
Sep 30, 2017 2,500.00
Sep 30, 2017 2,500.00
Jun 30, 2017 2,500.00
Jun 30, 2017 2,500.00
Mar 31, 2017 525,000.00
Mar 31, 2017 525,000.00